1. Home
  2. BDJ vs HRMY Comparison

BDJ vs HRMY Comparison

Compare BDJ & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDJ
  • HRMY
  • Stock Information
  • Founded
  • BDJ 2005
  • HRMY 2017
  • Country
  • BDJ United States
  • HRMY United States
  • Employees
  • BDJ N/A
  • HRMY N/A
  • Industry
  • BDJ Finance Companies
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • BDJ Finance
  • HRMY Health Care
  • Exchange
  • BDJ Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • BDJ 1.5B
  • HRMY 2.0B
  • IPO Year
  • BDJ N/A
  • HRMY 2020
  • Fundamental
  • Price
  • BDJ $8.57
  • HRMY $34.50
  • Analyst Decision
  • BDJ
  • HRMY Strong Buy
  • Analyst Count
  • BDJ 0
  • HRMY 8
  • Target Price
  • BDJ N/A
  • HRMY $53.38
  • AVG Volume (30 Days)
  • BDJ 561.6K
  • HRMY 751.0K
  • Earning Date
  • BDJ 01-01-0001
  • HRMY 05-06-2025
  • Dividend Yield
  • BDJ 8.85%
  • HRMY N/A
  • EPS Growth
  • BDJ N/A
  • HRMY 13.13
  • EPS
  • BDJ N/A
  • HRMY 2.62
  • Revenue
  • BDJ N/A
  • HRMY $744,852,000.00
  • Revenue This Year
  • BDJ N/A
  • HRMY $20.35
  • Revenue Next Year
  • BDJ N/A
  • HRMY $17.42
  • P/E Ratio
  • BDJ N/A
  • HRMY $13.16
  • Revenue Growth
  • BDJ N/A
  • HRMY 20.62
  • 52 Week Low
  • BDJ $6.91
  • HRMY $26.47
  • 52 Week High
  • BDJ $8.66
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • BDJ 55.90
  • HRMY 58.40
  • Support Level
  • BDJ $8.47
  • HRMY $33.47
  • Resistance Level
  • BDJ $8.63
  • HRMY $35.35
  • Average True Range (ATR)
  • BDJ 0.10
  • HRMY 1.13
  • MACD
  • BDJ -0.00
  • HRMY -0.10
  • Stochastic Oscillator
  • BDJ 55.88
  • HRMY 42.41

About BDJ Blackrock Enhanced Equity Dividend Trust

BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: